It includes Prenibiotics, a rice-based postbiotic with dual benefits for the gut and skin, making it the company’s first postbiotic product.
“Postbiotics allows us to make both a skin health claim, which is a very large segment of nutraceuticals, and a digestive claim,” Dow said. “The advantage of postbiotics is that they are stable, and they are stable across a variety of end-use markets, including pet food, food, beverages, and supplements. I see it as an access point.”
Dow also mentioned new science and clinical programs that are emerging around innate immunity, which is the immunity that everyone is born with, but which most people around the world have in their diets. He explained that immunity is compromised due to a lack of diversity. By taking Wellmune, a beta-glucan from baker’s yeast originally developed by Kerry, it is believed that “increasing immunity can prevent the development of many health conditions that can occur due to an inherently weakened immune system.” “We can do that,” Dow added.
In cognitive health, one of the hottest and leading supplement categories right now, Kelly introduced Sensoril Ashwagandha extract.
“A lot of effort has gone into developing ashwagandha and some probiotics that have clinical efficacy that can treat conditions that at one point could only be treated with drugs,” he said. “Ashwagandha is definitely part of what has allowed cognitive health to become such a relevant platform. What we are offering is a very unique take on ashwagandha. It uses both leaf and root extracts, which makes it very different from most ashwagandha players out there.”
Dow added that Kelly is not positioning Sensoril as an ashwagandha-based product, but rather as offering distinct health benefits for concentration, stress and, soon to be introduced, menopausal stress relief. . All of these applications are undergoing clinical trials, he said.
Other topics covered include how Kerry Proactive Health leverages the taste abilities of parent company Kerry Group’s popular supplement formats, how the company’s products improve gut health and the ubiquitous These included the use of GLP-1 agonists and whether they can address symptoms of obesity comorbidities.